Zevra Therapeutics Inc
NASDAQ:ZVRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
US |
|
S
|
Schloss Wachenheim AG
F:SWA
|
DE |
|
C
|
CSPC Pharmaceutical Group Ltd
F:CVGU
|
CN |
|
G
|
Greatland Resources Ltd
F:U0Y
|
AU |
|
F
|
Fortis Inc
F:12F
|
CA |
|
IDEX Corp
NYSE:IEX
|
US |
|
Stingray Group Inc
TSX:RAY.A
|
CA |
|
C
|
Cognizant Technology Solutions Corp
DUS:COZ
|
US |
|
TCM Group A/S
CSE:TCM
|
DK |
|
S
|
Stora Enso Oyj
OMXH:STERV
|
FI |
Intrinsic Value
The intrinsic value for Zevra Therapeutics Inc (ZVRA) under the Base Case is hidden USD. Compared with the current market price of 12.65 USD, the stock appears hidden .
ZVRA looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ZVRA is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Zevra Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Zevra Therapeutics Inc
Earnings Waterfall
Zevra Therapeutics Inc
The intrinsic value for Zevra Therapeutics Inc (ZVRA) under the Base Case is hidden USD.
Compared with the current market price of 12.65 USD, the stock appears hidden.